Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 2, 2014, Pages 439-447

  Slifka, Mark K ^a   Leung, Donald Y M ^e   Hammarlund, Erika ^a   Raué, Hans Peter ^a   Simpson, Eric L ^b   Tofte, Susan ^b   Baig Lewis, Shahana ^b   David, Gloria ^c   Lynn, Henry ^c   Woolson, Rob ^c   Hata, Tissa ^d   Milgrom, Henry ^e   Hanifin, Jon ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c RHO INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

Author keywords

antibody; atopic dermatitis; IgE; T cell memory; Yellow fever virus

Indexed keywords

AD; ADVERSE EVENT; AE; ANTIBODY; ATOPIC DERMATITIS; IGE; LNI; LOG NEUTRALIZING INDEX; NEUTRALIZING TITER 50; NT(50); T-CELL MEMORY; YELLOW FEVER VIRUS; YFV;

ADMINISTRATION, CUTANEOUS; ADULT; ANTIBODIES, VIRAL; CELLS, CULTURED; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTES, MONONUCLEAR; MALE; RNA, VIRAL; T-LYMPHOCYTES; VACCINATION; VIREMIA; YELLOW FEVER; YELLOW FEVER VACCINE;

EID: 84895063557     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.10.037     Document Type: Article

References (30)

1. T. Bieber Atopic dermatitis N Engl J Med 358 2008 1483 1494
2. C.N. Ellis, L.A. Drake, M.M. Prendergast, W. Abramovits, M. Boguniewicz, and C.R. Daniel et al. Cost of atopic dermatitis and eczema in the United States J Am Acad Dermatol 46 2002 361 370
3. L.A. Beck, M. Boguniewicz, T. Hata, L.C. Schneider, J. Hanifin, and R. Gallo et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum J Allergy Clin Immunol 124 2009 260 269, e1-7
4. J.M. Lane, F.L. Ruben, E. Abrutyn, and J.D. Millar Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968 JAMA 212 1970 441 444
5. J.L. Reed, D.E. Scott, and M. Bray Eczema vaccinatum Clin Infect Dis 54 2012 832 840
6. J.D. Grabenstein, and W. Winkenwerder Jr. US military smallpox vaccination program experience JAMA 289 2003 3278 3282
7. D.A. Cannon, F. Dewhurst, and P.D. Meers Mass vaccination against yellow fever by scarification with 17D strain vaccine Ann Trop Med Parasitol 51 1957 256 263
8. P.D. Meers Yellow fever vaccination by scarification with the 17D strain: an appreciation of the present position Trans R Soc Trop Med Hyg 51 1957 338 345
9. P.D. Meers Further observations on 17D-yellow fever vaccination by scarification, with and without simultaneous smallpox vaccination Trans R Soc Trop Med Hyg 54 1960 493 501
10. T.P. Monath, M.S. Cetron, and D.E. Teuwen Yellow fever vaccine S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 5th ed. 2008 Saunders/Elsevier Amsterdam 959 1056
11. T.P. Monath, R. Nichols, W.T. Archambault, L. Moore, R. Marchesani, and J. Tian et al. Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial Am J Trop Med Hyg 66 2002 533 541
12. T.P. Monath, E. Fowler, C.T. Johnson, J. Balser, M.J. Morin, and M. Sisti et al. An inactivated cell-culture vaccine against yellow fever N Engl J Med 364 2011 1326 1333
13. B. Reinhardt, R. Jaspert, M. Niedrig, C. Kostner, and J. L'Age-Stehr Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection J Med Virol 56 1998 159 167
14. E. Hammarlund, M.W. Lewis, S.G. Hansen, L.I. Strelow, J.A. Nelson, and G.J. Sexton et al. Duration of antiviral immunity after smallpox vaccination Nat Med 9 2003 1131 1137
15. J. Sun, Q. Zhao, and X. Zhao Generalized log-rank tests for interval-censored failure time data Scand J Stat 32 2005 49 57
16. I.J. Amanna, I. Messaoudi, and M.K. Slifka Protective immunity following vaccination: How is it defined? Hum Vaccin 4 2008 316 319
17. J.D. Miller, R.G. van der Most, R.S. Akondy, J.T. Glidewell, S. Albott, and D. Masopust et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines Immunity 28 2008 710 722
18. R.S. Akondy, N.D. Monson, J.D. Miller, S. Edupuganti, D. Teuwen, and H. Wu et al. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response J Immunol 183 2009 7919 7930
19. N. Laske, and B. Niggemann Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol 15 2004 86 88
20. C.H. Dean, J.B. Alarcon, A.M. Waterston, K. Draper, R. Early, and F. Guirakhoo et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates Hum Vaccin 1 2005 106 111
21. A.H. Roukens, A.C. Vossen, P.J. Bredenbeek, J.T. van Dissel, and L.G. Visser Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial PLoS One 3 2008 e1993
22. N.P. Lindsey, B.A. Schroeder, E.R. Miller, M.M. Braun, A.F. Hinckley, and N. Marano et al. Adverse event reports following yellow fever vaccination Vaccine 26 2008 6077 6082
23. A.D. Barrett, T.P. Monath, V. Barban, M. Niedrig, and D.E. Teuwen 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005 Vaccine 25 2007 2758 2765
24. J.K. Hickling, K.R. Jones, M. Friede, D. Zehrung, D. Chen, and D. Kristensen Intradermal delivery of vaccines: potential benefits and current challenges Bull World Health Organ 89 2011 221 226
25. F. Marra, F. Young, K. Richardson, and C.A. Marra A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events Influenza Other Respir Viruses 7 2013 584 603
26. R.J. Pettis, and A.J. Harvey Microneedle delivery: clinical studies and emerging medical applications Ther Deliv 3 2012 357 371
27. S. Al-Zahrani, M. Zaric, C. McCrudden, C. Scott, A. Kissenpfennig, and R.F. Donnelly Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy Expert Opin Drug Deliv 9 2012 541 550
28. R.R. Redfield, B.L. Innis, R.M. Scott, H.G. Cannon, and W.H. Bancroft Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy JAMA 254 1985 3203 3206
29. R.T. Kenney, S.A. Frech, L.R. Muenz, C.P. Villar, and G.M. Glenn Dose sparing with intradermal injection of influenza vaccine N Engl J Med 351 2004 2295 2301
30. R.B. Belshe, F.K. Newman, J. Cannon, C. Duane, J. Treanor, and C. Van Hoecke et al. Serum antibody responses after intradermal vaccination against influenza N Engl J Med 351 2004 2286 2294